Our senior expert speakers have been drawn from the life science industry, UK and EU regulatory authorities, the Department of Health and Social Care, NHS England, the National Institute for Health and Care Excellence (NICE), academia, research charities, and patient organisations.
Taking place at 30 Euston Square on Tuesday 17th September, our speakers will discuss:
- The UK’s global capability for clinical trials
- Bringing innovative medicines to market
- Evidence generation in support of regulatory decision-making
- Looking into the future – role of the regulator as part of the global innovation ecosystem
The Brexit implications for the UK regulatory environment will be considered in the discussions at this must attend one-day conference.
We are delighted to have confirmed keynote addresses from both Dr Ian Hudson, Chief Executive at Medicines and Healthcare products Regulatory Agency (UK), and Dr Lorraine Nolan, Chief Executive at Health Products Regulatory Authority (Ireland).
The conference will end with a networking drinks reception, allowing attendees plenty of opportunity to continue discussions and build their contacts within this area.
If you have any questions regarding the conference or registration process, please contact Georgina.